C9150 – Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9150
- Long description
- Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- Short description
- Xe129 xenon, diagnostic
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
I1EStandard imaging - nuclear medicine- Cross reference
- A9610
- Added
- July 1, 2023
- Last change
- October 1, 2024 – No change
- Termination date
- September 30, 2024
Frequently asked questions
What is HCPCS code C9150?
C9150 is a HCPCS Level II code for xenon xe-129 hyperpolarized gas, diagnostic, per study dose. It was discontinued on September 30, 2024.
Does Medicare cover C9150?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9142 – Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
- C9143 – Cocaine hydrochloride nasal solution (numbrino), 1 mg
- C9144 – Injection, bupivacaine (posimir), 1 mg
- C9145 – Injection, aprepitant, (aponvie), 1 mg
- C9146 – Injection, mirvetuximab soravtansine-gynx, 1 mg
- C9147 – Injection, tremelimumab-actl, 1 mg
- C9148 – Injection, teclistamab-cqyv, 0.5 mg
- C9149 – Injection, teplizumab-mzwv, 5 mcg
- C9151 – Injection, pegcetacoplan, 1 mg
- C9152 – Injection, aripiprazole, (abilify asimtufii), 1 mg
- C9153 – Injection, amisulpride, 1 mg
- C9154 – Injection, buprenorphine extended-release (brixadi), 1 mg
- C9155 – Injection, epcoritamab-bysp, 0.16 mg
- C9156 – Flotufolastat f 18, diagnostic, 1 millicurie
- C9157 – Injection, tofersen, 1 mg
- C9158 – Injection, risperidone, (uzedy), 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.